مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

780
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

PREVALENCE OF HEPATITIS C VIRUS ANTIBODY AND THE RISK FACTORS FOR THALASSEMIA AND HEMOPHILIA PATIENTS IN MARKAZI PROVINCE

Pages

  23-34

Abstract

 Background and Aim: Patients with HEMOPHILIA and THALASSEMIA are at high risk for HEPATITIS C VIRUS (HCV) infections. Unscreened blood and blood products are thought to be the most important RISK FACTORS in these two groups.Materials and Methods: Blood samples were collected from 98 THALASSEMIA patients and 74 HEMOPHILIAcs in Markazi province. The presence of anti-HCV antibody was tested by a third generation enzyme immunoassay. All ELISA-reactive samples were tested with the confirmatory third-generation recombinant irnrnunoblot assay RIBA. We used a specially designed questionnaire to obtain data from patients and the software package SPSS 11.5 for statistical analysis.Results: HCV antibody was detected in 5 THALASSEMIA patients (5.1%) and 31 HEMOPHILIAcs (41.9%). Anti-HCV positivity in patients with THALASSEMIA was associated with the total volume of the transfusions, splenectomy, and the duration of treatment. In HEMOPHILIAcs, seropositivity was significantly associated with the duration of transfusion treatment (P=0.01) and disease severity (P=0.00).The prevalence of HCV antibody in THALASSEMIA subjects dropped from 8.1% to 0% after the implementation of anti-HCV screening in1996. Conclusion: In Markazi province, the current policy of screening donors for anti- HCV and the strict safety controls on factor concentrates can effectively protect THALASSEMIA and HEMOPHILIA patients from HCV infection.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    SAMIMIRAD, K., SHAHBAZ, B., MAHMOUDI, MAHMOUD, NOUROUZI, MAHDI, & FAYAZ VASEGHI, M.. (2007). PREVALENCE OF HEPATITIS C VIRUS ANTIBODY AND THE RISK FACTORS FOR THALASSEMIA AND HEMOPHILIA PATIENTS IN MARKAZI PROVINCE. JOURNAL OF SCHOOL OF PUBLIC HEALTH AND INSTITUTE OF PUBLIC HEALTH RESEARCH, 5(3), 23-34. SID. https://sid.ir/paper/84965/en

    Vancouver: Copy

    SAMIMIRAD K., SHAHBAZ B., MAHMOUDI MAHMOUD, NOUROUZI MAHDI, FAYAZ VASEGHI M.. PREVALENCE OF HEPATITIS C VIRUS ANTIBODY AND THE RISK FACTORS FOR THALASSEMIA AND HEMOPHILIA PATIENTS IN MARKAZI PROVINCE. JOURNAL OF SCHOOL OF PUBLIC HEALTH AND INSTITUTE OF PUBLIC HEALTH RESEARCH[Internet]. 2007;5(3):23-34. Available from: https://sid.ir/paper/84965/en

    IEEE: Copy

    K. SAMIMIRAD, B. SHAHBAZ, MAHMOUD MAHMOUDI, MAHDI NOUROUZI, and M. FAYAZ VASEGHI, “PREVALENCE OF HEPATITIS C VIRUS ANTIBODY AND THE RISK FACTORS FOR THALASSEMIA AND HEMOPHILIA PATIENTS IN MARKAZI PROVINCE,” JOURNAL OF SCHOOL OF PUBLIC HEALTH AND INSTITUTE OF PUBLIC HEALTH RESEARCH, vol. 5, no. 3, pp. 23–34, 2007, [Online]. Available: https://sid.ir/paper/84965/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button